Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
5 hedge funds and large institutions have $164K invested in Medigus Ltd. Series C Warrant in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
56% less capital invested
Capital invested by funds: $370K → $164K (-$206K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$16.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$7K |
MDGSW Hedge Fund Activity: Q3 2022 in Review
5 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q3 2022, worth a combined $164K — down 56% from $370K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MDGSW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $16.1K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $7K sold.
- 5 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q3 2022, down from 6 in Q2 2022.
- Funds reported $164K of Medigus Ltd. Series C Warrant stock for Q3 2022, down 56% quarter-over-quarter.
- 0 funds opened new Medigus Ltd. Series C Warrant positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest Medigus Ltd. Series C Warrant buyer in Q3 2022 was UBS Group, an estimated $16.1K added.
- The largest Medigus Ltd. Series C Warrant seller in Q3 2022 was Warberg Asset Management, an estimated $7K sold.
Based on aggregated 13F filings for Q3 2022.